Register to chat with like-minded investors on our interactive forums.

Get Started

GLPG

Galapagos (GLPG)

Galapagos

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Date	Time	Source	Headline	Symbol	Company
01/06/2022	9:30AM	GlobeNewswire Inc.	Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference	EU:GLPG	Galapagos
01/06/2022	9:30AM	GlobeNewswire Inc.	Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference	EU:GLPG	Galapagos
12/03/2021	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
12/03/2021	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
11/22/2021	4:01PM	GlobeNewswire Inc.	Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease	EU:GLPG	Galapagos
11/22/2021	4:01PM	GlobeNewswire Inc.	Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease	EU:GLPG	Galapagos
11/15/2021	10:45AM	GlobeNewswire Inc.	Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis	EU:GLPG	Galapagos
11/15/2021	10:45AM	GlobeNewswire Inc.	Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis	EU:GLPG	Galapagos
11/04/2021	5:01PM	GlobeNewswire Inc.	Galapagos reports commercial and operational progress at Q3 financial results	EU:GLPG	Galapagos
11/04/2021	5:01PM	GlobeNewswire Inc.	Galapagos reports commercial and operational progress at Q3 financial results	EU:GLPG	Galapagos
10/04/2021	4:01PM	GlobeNewswire Inc.	Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress	EU:GLPG	Galapagos
10/04/2021	4:01PM	GlobeNewswire Inc.	Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress	EU:GLPG	Galapagos
10/04/2021	1:01AM	GlobeNewswire Inc.	Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease	EU:GLPG	Galapagos
10/04/2021	1:01AM	GlobeNewswire Inc.	Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease	EU:GLPG	Galapagos
09/20/2021	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
09/20/2021	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
09/17/2021	7:15AM	GlobeNewswire Inc.	GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS	EU:GLPG	Galapagos
09/17/2021	7:15AM	GlobeNewswire Inc.	GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS	EU:GLPG	Galapagos
08/30/2021	5:28PM	Dow Jones News	Galapagos NV CEO to Retire	EU:GLPG	Galapagos
08/30/2021	4:01PM	GlobeNewswire Inc.	Galapagos announces planned retirement of CEO	EU:GLPG	Galapagos
08/30/2021	4:01PM	GlobeNewswire Inc.	Galapagos announces planned retirement of CEO	EU:GLPG	Galapagos
08/05/2021	4:01PM	GlobeNewswire Inc.	Galapagos reports H1 financial results with refocused pipeline and operational progress	EU:GLPG	Galapagos
08/05/2021	4:01PM	GlobeNewswire Inc.	Galapagos reports H1 financial results with refocused pipeline and operational progress	EU:GLPG	Galapagos
07/15/2021	11:59AM	Dow Jones News	Galapagos ADRs Down After Study Data	EU:GLPG	Galapagos
07/14/2021	4:01PM	GlobeNewswire Inc.	Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study	EU:GLPG	Galapagos
07/14/2021	4:01PM	GlobeNewswire Inc.	Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study	EU:GLPG	Galapagos
07/14/2021	4:01PM	GlobeNewswire Inc.	Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation	EU:GLPG	Galapagos
07/14/2021	4:01PM	GlobeNewswire Inc.	Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation	EU:GLPG	Galapagos
07/10/2021	5:10AM	GlobeNewswire Inc.	Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in pat...	EU:GLPG	Galapagos
07/10/2021	5:10AM	GlobeNewswire Inc.	Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in pat...	EU:GLPG	Galapagos

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Ubiquitech Software (PK)

Fannie Mae (QB)

Brookmount Explorations (PK)

NioCorp Developments

Seven Arts Entertainment (PK)

Anavex Life Sciences

Decentral Life (PK)

Delayed Upgrade Clock